Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin

Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied immunohistochemistry & molecular morphology 2018-02, Vol.26 (2), p.94-100
Hauptverfasser: Czeczok, Thomas W, Stashek, Kristen M, Maxwell, Jessica E, O'Dorisio, Thomas M, Howe, James R, Hornick, Jason L, Bellizzi, Andrew M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 2
container_start_page 94
container_title Applied immunohistochemistry & molecular morphology
container_volume 26
creator Czeczok, Thomas W
Stashek, Kristen M
Maxwell, Jessica E
O'Dorisio, Thomas M
Howe, James R
Hornick, Jason L
Bellizzi, Andrew M
description Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuroendocrine tumors (NET) arising at most anatomic sites, with the exception of jejunoileal tumors, and that it is similarly not expressed by poorly differentiated neuroendocrine carcinomas (NEC). We sought to validate this result in a large cohort of NETs and NECs. Clusterin immunohistochemistry was performed on tissue microarrays of 255 NETs [45 lung, 4 stomach, 8 duodenum, 75 pancreas (62 primary, 13 metastatic), 107 jejunoileum (69 primary, 38 metastatic), 16 appendix] and 88 NECs (43 visceral, 45 Merkel cell). Extent (%) and intensity (0, 1+, 2+, 3+) of staining were assessed and an H-score (extent x intensity) calculated. An average H-score >5 was considered positive. Clusterin expression was noted in 82.4% of 148 nonjejunoileal NETs (average H-score 183) and only 8.4% of 107 jejunoileal NETs (average H-score, 31), as well as 19.3% of NECs (average H-score, 36). Clusterin is frequently, strongly expressed by NETs of diverse anatomic sites, with the exception of jejunoileal tumors, in which it is only rarely, weakly expressed. It is occasionally, weakly expressed by NECs. Most metastatic NETs of occult origin arise in the pancreas or the jejunoileum. For cases in which an initial site of origin immunopanel (eg, islet 1, PAX6, CDX2) is ambiguous, addition of clusterin may be diagnostically useful, with absence of expression suggesting a jejunoileal origin.
doi_str_mv 10.1097/PAI.0000000000000563
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5808989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2001062259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-5a1c39fd0433c3ccfdc3014f2922665a4ae77d96a6b90eeafd04491431c27bd03</originalsourceid><addsrcrecordid>eNpdUdtq3DAQFaEh9z8oxY99cTK62Gv1obAsm3bDkhS6IY9CK483CrLlSnZp3vvh0TYXthECDZpzzpzhEPKRwjkFObn4MV2cw-4pSr5HjmjBeS6gqD5sa0FzBrQ8JMcxPgAwxoU4IIdMCga84Efk78yNccBguyzdaxyDx672Jn1gNu_tcI_Oapc6vnc6tvFLNl1H7Axmvsnmf_qAMVr_j62zO3Qur23TYMBusHrAOluNrQ_Zz3GzwTjEBLrCh7Hz1mGSvQl2Y7tTst9oF_Hs5T0ht5fz1ex7vrz5tphNl7kRUA15oanhsqlBcG64MU1tOFDRMMlYWRZaaJxMalnqci0BUW-RQlLBqWGTdQ38hHx91u3HdYu1SR6DdqoPttXhUXlt1f-dzt6rjf-tigoqWckk8PlFIPhfY9pHtTaatLTu0I9RMQAKJWPFFiqeoSb4GAM2b2MoqG2AKgWo3geYaJ92Lb6RXhPjTzlNmZ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2001062259</pqid></control><display><type>article</type><title>Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Czeczok, Thomas W ; Stashek, Kristen M ; Maxwell, Jessica E ; O'Dorisio, Thomas M ; Howe, James R ; Hornick, Jason L ; Bellizzi, Andrew M</creator><creatorcontrib>Czeczok, Thomas W ; Stashek, Kristen M ; Maxwell, Jessica E ; O'Dorisio, Thomas M ; Howe, James R ; Hornick, Jason L ; Bellizzi, Andrew M</creatorcontrib><description>Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuroendocrine tumors (NET) arising at most anatomic sites, with the exception of jejunoileal tumors, and that it is similarly not expressed by poorly differentiated neuroendocrine carcinomas (NEC). We sought to validate this result in a large cohort of NETs and NECs. Clusterin immunohistochemistry was performed on tissue microarrays of 255 NETs [45 lung, 4 stomach, 8 duodenum, 75 pancreas (62 primary, 13 metastatic), 107 jejunoileum (69 primary, 38 metastatic), 16 appendix] and 88 NECs (43 visceral, 45 Merkel cell). Extent (%) and intensity (0, 1+, 2+, 3+) of staining were assessed and an H-score (extent x intensity) calculated. An average H-score &gt;5 was considered positive. Clusterin expression was noted in 82.4% of 148 nonjejunoileal NETs (average H-score 183) and only 8.4% of 107 jejunoileal NETs (average H-score, 31), as well as 19.3% of NECs (average H-score, 36). Clusterin is frequently, strongly expressed by NETs of diverse anatomic sites, with the exception of jejunoileal tumors, in which it is only rarely, weakly expressed. It is occasionally, weakly expressed by NECs. Most metastatic NETs of occult origin arise in the pancreas or the jejunoileum. For cases in which an initial site of origin immunopanel (eg, islet 1, PAX6, CDX2) is ambiguous, addition of clusterin may be diagnostically useful, with absence of expression suggesting a jejunoileal origin.</description><identifier>ISSN: 1541-2016</identifier><identifier>ISSN: 1533-4058</identifier><identifier>EISSN: 1533-4058</identifier><identifier>DOI: 10.1097/PAI.0000000000000563</identifier><identifier>PMID: 29420353</identifier><language>eng</language><publisher>United States</publisher><subject>Biomarkers, Tumor - metabolism ; Carcinoma, Neuroendocrine - diagnosis ; Carcinoma, Neuroendocrine - metabolism ; Clusterin - metabolism ; Cohort Studies ; Diagnosis, Differential ; Humans ; Immunohistochemistry ; Jejunal Neoplasms - diagnosis ; Jejunal Neoplasms - metabolism ; Neoplasms, Glandular and Epithelial - diagnosis ; Neoplasms, Glandular and Epithelial - metabolism ; Neuroendocrine Tumors - diagnosis ; Neuroendocrine Tumors - metabolism ; Tissue Array Analysis</subject><ispartof>Applied immunohistochemistry &amp; molecular morphology, 2018-02, Vol.26 (2), p.94-100</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-5a1c39fd0433c3ccfdc3014f2922665a4ae77d96a6b90eeafd04491431c27bd03</citedby><cites>FETCH-LOGICAL-c408t-5a1c39fd0433c3ccfdc3014f2922665a4ae77d96a6b90eeafd04491431c27bd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29420353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Czeczok, Thomas W</creatorcontrib><creatorcontrib>Stashek, Kristen M</creatorcontrib><creatorcontrib>Maxwell, Jessica E</creatorcontrib><creatorcontrib>O'Dorisio, Thomas M</creatorcontrib><creatorcontrib>Howe, James R</creatorcontrib><creatorcontrib>Hornick, Jason L</creatorcontrib><creatorcontrib>Bellizzi, Andrew M</creatorcontrib><title>Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin</title><title>Applied immunohistochemistry &amp; molecular morphology</title><addtitle>Appl Immunohistochem Mol Morphol</addtitle><description>Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuroendocrine tumors (NET) arising at most anatomic sites, with the exception of jejunoileal tumors, and that it is similarly not expressed by poorly differentiated neuroendocrine carcinomas (NEC). We sought to validate this result in a large cohort of NETs and NECs. Clusterin immunohistochemistry was performed on tissue microarrays of 255 NETs [45 lung, 4 stomach, 8 duodenum, 75 pancreas (62 primary, 13 metastatic), 107 jejunoileum (69 primary, 38 metastatic), 16 appendix] and 88 NECs (43 visceral, 45 Merkel cell). Extent (%) and intensity (0, 1+, 2+, 3+) of staining were assessed and an H-score (extent x intensity) calculated. An average H-score &gt;5 was considered positive. Clusterin expression was noted in 82.4% of 148 nonjejunoileal NETs (average H-score 183) and only 8.4% of 107 jejunoileal NETs (average H-score, 31), as well as 19.3% of NECs (average H-score, 36). Clusterin is frequently, strongly expressed by NETs of diverse anatomic sites, with the exception of jejunoileal tumors, in which it is only rarely, weakly expressed. It is occasionally, weakly expressed by NECs. Most metastatic NETs of occult origin arise in the pancreas or the jejunoileum. For cases in which an initial site of origin immunopanel (eg, islet 1, PAX6, CDX2) is ambiguous, addition of clusterin may be diagnostically useful, with absence of expression suggesting a jejunoileal origin.</description><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Neuroendocrine - diagnosis</subject><subject>Carcinoma, Neuroendocrine - metabolism</subject><subject>Clusterin - metabolism</subject><subject>Cohort Studies</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Jejunal Neoplasms - diagnosis</subject><subject>Jejunal Neoplasms - metabolism</subject><subject>Neoplasms, Glandular and Epithelial - diagnosis</subject><subject>Neoplasms, Glandular and Epithelial - metabolism</subject><subject>Neuroendocrine Tumors - diagnosis</subject><subject>Neuroendocrine Tumors - metabolism</subject><subject>Tissue Array Analysis</subject><issn>1541-2016</issn><issn>1533-4058</issn><issn>1533-4058</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUdtq3DAQFaEh9z8oxY99cTK62Gv1obAsm3bDkhS6IY9CK483CrLlSnZp3vvh0TYXthECDZpzzpzhEPKRwjkFObn4MV2cw-4pSr5HjmjBeS6gqD5sa0FzBrQ8JMcxPgAwxoU4IIdMCga84Efk78yNccBguyzdaxyDx672Jn1gNu_tcI_Oapc6vnc6tvFLNl1H7Axmvsnmf_qAMVr_j62zO3Qur23TYMBusHrAOluNrQ_Zz3GzwTjEBLrCh7Hz1mGSvQl2Y7tTst9oF_Hs5T0ht5fz1ex7vrz5tphNl7kRUA15oanhsqlBcG64MU1tOFDRMMlYWRZaaJxMalnqci0BUW-RQlLBqWGTdQ38hHx91u3HdYu1SR6DdqoPttXhUXlt1f-dzt6rjf-tigoqWckk8PlFIPhfY9pHtTaatLTu0I9RMQAKJWPFFiqeoSb4GAM2b2MoqG2AKgWo3geYaJ92Lb6RXhPjTzlNmZ4</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Czeczok, Thomas W</creator><creator>Stashek, Kristen M</creator><creator>Maxwell, Jessica E</creator><creator>O'Dorisio, Thomas M</creator><creator>Howe, James R</creator><creator>Hornick, Jason L</creator><creator>Bellizzi, Andrew M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20180201</creationdate><title>Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin</title><author>Czeczok, Thomas W ; Stashek, Kristen M ; Maxwell, Jessica E ; O'Dorisio, Thomas M ; Howe, James R ; Hornick, Jason L ; Bellizzi, Andrew M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-5a1c39fd0433c3ccfdc3014f2922665a4ae77d96a6b90eeafd04491431c27bd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Neuroendocrine - diagnosis</topic><topic>Carcinoma, Neuroendocrine - metabolism</topic><topic>Clusterin - metabolism</topic><topic>Cohort Studies</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Jejunal Neoplasms - diagnosis</topic><topic>Jejunal Neoplasms - metabolism</topic><topic>Neoplasms, Glandular and Epithelial - diagnosis</topic><topic>Neoplasms, Glandular and Epithelial - metabolism</topic><topic>Neuroendocrine Tumors - diagnosis</topic><topic>Neuroendocrine Tumors - metabolism</topic><topic>Tissue Array Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Czeczok, Thomas W</creatorcontrib><creatorcontrib>Stashek, Kristen M</creatorcontrib><creatorcontrib>Maxwell, Jessica E</creatorcontrib><creatorcontrib>O'Dorisio, Thomas M</creatorcontrib><creatorcontrib>Howe, James R</creatorcontrib><creatorcontrib>Hornick, Jason L</creatorcontrib><creatorcontrib>Bellizzi, Andrew M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Applied immunohistochemistry &amp; molecular morphology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Czeczok, Thomas W</au><au>Stashek, Kristen M</au><au>Maxwell, Jessica E</au><au>O'Dorisio, Thomas M</au><au>Howe, James R</au><au>Hornick, Jason L</au><au>Bellizzi, Andrew M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin</atitle><jtitle>Applied immunohistochemistry &amp; molecular morphology</jtitle><addtitle>Appl Immunohistochem Mol Morphol</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>26</volume><issue>2</issue><spage>94</spage><epage>100</epage><pages>94-100</pages><issn>1541-2016</issn><issn>1533-4058</issn><eissn>1533-4058</eissn><abstract>Clusterin, a widely expressed, tissue-specific glycoprotein, is a diagnostic marker of several tumor types, including anaplastic large cell lymphoma, follicular dendritic cell sarcoma, and tenosynovial giant cell tumor. A recent study has suggested it is highly expressed by well-differentiated neuroendocrine tumors (NET) arising at most anatomic sites, with the exception of jejunoileal tumors, and that it is similarly not expressed by poorly differentiated neuroendocrine carcinomas (NEC). We sought to validate this result in a large cohort of NETs and NECs. Clusterin immunohistochemistry was performed on tissue microarrays of 255 NETs [45 lung, 4 stomach, 8 duodenum, 75 pancreas (62 primary, 13 metastatic), 107 jejunoileum (69 primary, 38 metastatic), 16 appendix] and 88 NECs (43 visceral, 45 Merkel cell). Extent (%) and intensity (0, 1+, 2+, 3+) of staining were assessed and an H-score (extent x intensity) calculated. An average H-score &gt;5 was considered positive. Clusterin expression was noted in 82.4% of 148 nonjejunoileal NETs (average H-score 183) and only 8.4% of 107 jejunoileal NETs (average H-score, 31), as well as 19.3% of NECs (average H-score, 36). Clusterin is frequently, strongly expressed by NETs of diverse anatomic sites, with the exception of jejunoileal tumors, in which it is only rarely, weakly expressed. It is occasionally, weakly expressed by NECs. Most metastatic NETs of occult origin arise in the pancreas or the jejunoileum. For cases in which an initial site of origin immunopanel (eg, islet 1, PAX6, CDX2) is ambiguous, addition of clusterin may be diagnostically useful, with absence of expression suggesting a jejunoileal origin.</abstract><cop>United States</cop><pmid>29420353</pmid><doi>10.1097/PAI.0000000000000563</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1541-2016
ispartof Applied immunohistochemistry & molecular morphology, 2018-02, Vol.26 (2), p.94-100
issn 1541-2016
1533-4058
1533-4058
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5808989
source MEDLINE; Journals@Ovid Complete
subjects Biomarkers, Tumor - metabolism
Carcinoma, Neuroendocrine - diagnosis
Carcinoma, Neuroendocrine - metabolism
Clusterin - metabolism
Cohort Studies
Diagnosis, Differential
Humans
Immunohistochemistry
Jejunal Neoplasms - diagnosis
Jejunal Neoplasms - metabolism
Neoplasms, Glandular and Epithelial - diagnosis
Neoplasms, Glandular and Epithelial - metabolism
Neuroendocrine Tumors - diagnosis
Neuroendocrine Tumors - metabolism
Tissue Array Analysis
title Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clusterin%20in%20Neuroendocrine%20Epithelial%20Neoplasms:%20Absence%20of%20Expression%20in%20a%20Well-differentiated%20Tumor%20Suggests%20a%20Jejunoileal%20Origin&rft.jtitle=Applied%20immunohistochemistry%20&%20molecular%20morphology&rft.au=Czeczok,%20Thomas%20W&rft.date=2018-02-01&rft.volume=26&rft.issue=2&rft.spage=94&rft.epage=100&rft.pages=94-100&rft.issn=1541-2016&rft.eissn=1533-4058&rft_id=info:doi/10.1097/PAI.0000000000000563&rft_dat=%3Cproquest_pubme%3E2001062259%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2001062259&rft_id=info:pmid/29420353&rfr_iscdi=true